HIGHLIGHTS
- who: Wendy E. Heywood from the Centre for Translational Omics, University College London Institute of Child Health, Guilford Street, London WC N EH, UK have published the paper: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay, in the Journal: (JOURNAL)
- what: Markers for LBD are greatly needed therefore the profiling part of this study was focused on identifying an LBD CSF protein signature that could then be tested against other neurodegenerative conditions such as AD and PD. The assay described in this study had been . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.